2019.02.25
2018.08.09
BioWorld August 9, 2018: South Korea’s ABL Bio buys bispecific antibodies from I-Mab in $100M deal
Read at BioWorld2018.07.30
the Pharma Letter July 30, 2018: The ambition behind the I-Mab/ABL Bio deal
Read at the Pharma Letter2018.06.29
The Wall Street Journal Jun 29, 2018: I-Mab Biopharma Closes $220 Million Series C
Read at The Wall Street Journal2018.01.03